Apple's Cook Heads ...
Health Care: Drugs
Regulus Therapeutics Inc (RGLS: NASDAQ)
$7.00 -0.10 | -1.41%
05/20/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | |||
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -17.41M | -7.60M | ||
| Operating Gains/Losses | 4.72M | -1.00K | ||
| Extraordinary Gains / Losses | 0.00 | 0.00 | ||
| (Increase) Decrease In Receivables | 0.00 | 0.00 | ||
| (Increase) Decrease in Inventories | 0.00 | 0.00 | ||
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | ||
| (Decrease) Increase In Payables | -189.00K | -793.00K | ||
| (Decrease) Increase In Other Current Liabilities | 657.00K | -174.00K | ||
| (Increase) Decrease In Other Working Capital | 823.00K | -8.64M | ||
| Other Non-Cash Items | 1.55M | 825.00K | ||
| Net Cash From Continuing Operations | -8.72M | -15.06M | ||
| Net Cash From Discontinued Operations | 0.00 | 0.00 | ||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -8.72M | -15.06M | ||
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | ||
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 33.08M | 54.58M | ||
| Purchases of Property, Plant & Equipment | -1.43M | -598.00K | ||
| Acquisitions | 0.00 | 0.00 | ||
| Purchases of Short-Term Investments | -62.04M | -50.66M | ||
| Other Cash from Investing Activities | 0.00 | 0.00 | ||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -30.38M | 3.32M | ||
| Issuance of Debt | 5.00M | 0.00 | ||
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 65.93M | 58.00K | ||
| Repayment of Long-Term Debt | -445.00K | -412.00K | ||
| Repurchase of Capital Stock | 0.00 | 0.00 | ||
| Payment of Cash Dividends | 0.00 | 0.00 | ||
| Other Financing Charges, Net | 0.00 | 0.00 | ||
| Net Cash From Financing Activities | 70.48M | -354.00K | ||
| Effect of Exchange Rate Changes | 0.00 | 0.00 | ||
| Net Change in Cash & Cash Equivalents | 31.38M | -12.09M | ||
Portfolios with RGLS
- Portfolio NameUser Type
Latest RGLS Headlines from TheStreet
- 8 Stocks Roaring Higher on Unusual Volume 12.27.12 | 03:12 pm
- Cramer's 'Mad Money' Recap: Focus on What Matters 10.15.12 | 07:10 pm
- IPOs: LifeLock, Luxfer, Regulus
10.02.12 | 06:10 am
Press Releases for RGLS
- Regulus Announces Timing For First Quarter 2013 Financial Results Webcast And Conference Call - PR Newswire 05.07.13 | 04:05 pm
- Regulus To Present At 12th Annual Needham Healthcare Conference - PR Newswire 04.24.13 | 04:04 pm
- Zosano Pharma, Inc. Expands Board Of Directors With Addition Of Kleanthis G. Xanthopoulos, Ph.D. - PR Newswire 04.15.13 | 11:04 am
- Regulus Appoints William H. Rastetter, Ph.D. To Its Board Of Directors - PR Newswire 04.01.13 | 08:04 am
- Regulus To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.28.13 | 04:03 pm
- Regulus To Present At Cowen And Company 33rd Annual Healthcare Conference - PR Newswire 02.26.13 | 04:02 pm
- Regulus Announces Timing For Fourth Quarter And Year-End 2012 Financial Results Webcast And Conference Call - PR Newswire 02.13.13 | 04:02 pm
- Regulus To Present At Two Upcoming Investor Conferences - PR Newswire 02.04.13 | 04:02 pm
- Regulus Appoints Mark G. Foletta To Its Board Of Directors - PR Newswire 01.31.13 | 08:01 am
- Regulus To Present At 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.13 | 04:01 pm
Partner Headlines for RGLS
- UPDATE: Wedbush Securities Initiates Regulus Therapeutics at Outperform on Pipeline Progress - Benzinga 11.29.12 | 01:11 pm
- Regulus Therapeutics: Serious Red Flags At This Public Offering - Seeking Alpha 10.08.12 | 09:10 am
- Six More IPOs this Week - NASDAQ 10.05.12 | 09:10 pm
